SHC NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Sotera Health Co · Healthcare · Diagnostics & Research

Open interactive chart View report data Download investor PDF
Latest close 17.35 USD
-2.3% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is 5.7% above the Trend Line and sits at 71.8% of its 52-week range. The latest completed week returned -2.3%, after a -0.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 50/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: earnings are due in 7d.

Setup score 48 out of 100
Latest Close 17.35 USD 24 Jul 2026
1W Return -2.3% latest completed week
4W Return -0.2% short-term follow-through
12W Return 11.9% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.3% Latest completed week; four-week move -0.2%. Indicator stack 30/72 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 50/100 conviction; expected move 10.1%. News sentiment 52/100 48 relevant articles in the latest sentiment read. Event risk 7d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 5.7% above the Trend Line and sits at 71.8% of its 52-week range. The latest completed week returned -2.3%, after a -0.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4412-week average 0.19

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.44Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -0.2% over four weeks, 11.9% over 12 weeks, and 41.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.3%
4W-0.2%
12W11.9%
26W-6.3%
52W41.1%
Active trend streak0 weeks
Active weeks in one year28
Trend breadth53.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.88Latest activity-pressure read.
Pressure change75.4%Four-week change in activity pressure.
Leadership-2.04Latest relative-leadership reading.
RS change45.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength55/100Blend of value, momentum, and quality. Underlying universe rank 46; rank 1 is best.
Value17/100Relative valuation strength. Underlying universe rank 84; rank 1 is best.
Quality88/100Profitability and accounting quality. Underlying universe rank 13; rank 1 is best.
Momentum83/100Medium-term price momentum. Underlying universe rank 18; rank 1 is best.
Growth90/100Revenue and earnings growth. Underlying universe rank 11; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework46/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
42.0x
Price divided by trailing earnings.
Price / sales
4.2x
Market value relative to trailing revenue.
EV / EBITDA
14.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
55.0%
Gross profit retained from each unit of revenue.
Operating margin
29.8%
Operating profit retained from revenue.
Free-cash-flow margin
35.8%
Free cash flow generated from revenue.
Return on invested capital
7.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.4%
Latest one-year revenue growth.
EPS growth
374.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-1.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
4.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

SHC shows volatility options pressure with a 50/100 conviction score, put-call volume ratio of 0.00, expected move of 10.1%, and Sharemaestro trend signal inactive.

Conviction50/100
Expected move10.1%
Put/call volume0.00
Pressure100
Speculation1
Volatility77
Trend agreement0
Open options detail
Insider activity13 / 3

13 acquisitions and 3 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 48 relevant articles.

14 positive · 27 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings7dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move10.1%Nearest-chain priced movement where available.
52-week drawdown-12.6%Distance below the 52-week high.
13-week volatility3.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+13.9%Week of 3 Apr.
Worst week-9.8%Week of 6 Mar.
Latest week-2.3%Week of 24 Jul.

Shape of recent returns

Strong gains3
Modest gains8
Flat weeks0
Modest losses11
Sharp losses4
Recent vol3.5%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew5.3% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape45/100

Trend, activity pressure, participation, and risk combine to a 45/100 tape read.

 Indicator analysis28/100

Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.44; 2 reversal markers Factors60/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 60; Small Cap Core rank 94 SVQF46/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 391.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options35/100

SHC shows volatility options pressure with a 50/100 conviction score, put-call volume ratio of 0.00, expected move of 10.1%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 10.1% Sentiment52/100

Weighted news tone is neutral across 48 relevant articles.

Sotera Health sets Q2 2026 earnings release for August 6 Insiders13 / 3

13 acquisitions and 3 disposals in the latest 180-day insider tape.

 Earnings7d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202617.35 USD-2.3%16.42 USD14.47 USD0.88-2.0415.7MOff
17 Jul 202617.75 USD-3.6%16.43 USD14.48 USD0.94-1.1214.5MOff
10 Jul 202618.42 USD2.7%16.41 USD14.48 USD0.82-1.2414.2MOff
3 Jul 202617.93 USD3.2%16.36 USD14.49 USD0.69-1.8310.7MOff
26 Jun 202617.38 USD9.9%16.32 USD14.49 USD0.50-3.7314.9MOff
19 Jun 202615.82 USD-2.3%16.32 USD14.50 USD0.26-16.079.9MOff
12 Jun 202616.19 USD3.6%16.34 USD14.51 USD0.15-11.8313.3MOff
5 Jun 202615.62 USD-0.1%16.32 USD14.50 USD0.07-12.9312.6MOff
29 May 202615.64 USD-0.1%16.32 USD14.50 USD0.06-16.8210.9MOff
22 May 202615.66 USD2.6%16.35 USD14.49 USD-0.05-14.4613.6MOff
15 May 202615.27 USD-3.2%16.39 USD14.48 USD-0.21-15.7140.5MOff
8 May 202615.78 USD1.8%16.42 USD14.48 USD-0.40-13.3823.1MOff
1 May 202615.50 USD-0.5%16.41 USD14.47 USD-0.61-10.5613.4MOff
24 Apr 202615.58 USD-4.4%16.42 USD14.47 USD-0.69-8.8810.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.